A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention

Código QR

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention

Guardado en:

Detalles Bibliográficos
Autores principales:	Qian Zeng, Long-Dan Zhang, Wei Wang
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/501157825b7b4ead89708170c3569f80
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Apixaban for massive intracoronary thrombosis: A case series
por: Kerim Esenboğa, et al.
Publicado: (2021)

Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice
por: Kenan Yalta, et al.
Publicado: (2021)

The Value of Intracoronary Imaging and Coronary Physiology When Treating Calcified Lesions
por: Yasushi Ueki, et al.
Publicado: (2019)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Jianwei Zhang, et al.
Publicado: (2021)

Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
por: Mustafa Kürşat Tigen, et al.
Publicado: (2021)

The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures – Systematic review and meta-analysis of randomized controlled trials
por: Raymond Pranata, et al.
Publicado: (2021)

COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW
por: Mohsin Saif, et al.
Publicado: (2020)

Left Ventricular End-Diastolic Pressure and B-Type Natriuretic Peptide Levels Guidance of Low-Dose Furosemide Treatment to Prevent Contrast-Induced Nephropathy in Patients with Percutaneous Coronary Intervention: A Randomized Controlled Trial
por: Guoqiang Gu, et al.
Publicado: (2021)

Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Sheng-Lin Ye MD, et al.
Publicado: (2021)

The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis
por: Xiangwen Liang, et al.
Publicado: (2021)

Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention: Evidence from Observational Studies and Randomized Controlled Trials
por: Xiao-Fei Gao, et al.
Publicado: (2020)

Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
por: Qiao Yu Shao, et al.
Publicado: (2021)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)

Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta‐analysis of randomized controlled trials
por: Jakrin Kewcharoen, et al.
Publicado: (2021)

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
por: Johny Nicolas, et al.
Publicado: (2020)

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials
por: Danielle Haanschoten, et al.
Publicado: (2021)

Dosing Time Matters? Nighttime vs. Daytime Administration of Nifedipine Gastrointestinal Therapeutic System (GITS) or Amlodipine on Non-dipper Hypertension: A Randomized Controlled Trial of NARRAS
por: Jing Liu, et al.
Publicado: (2021)

Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021)

Influence of Dexmedetomidine on Post-operative Atrial Fibrillation After Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials
por: Sheng Peng, et al.
Publicado: (2021)

The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations
por: Nilofer Sorathia, et al.
Publicado: (2019)

The EXCEL Trial: The Interventionalists’ Perspective
por: George William Hunter, et al.
Publicado: (2021)

The EXCEL Trial: The Surgeons’ Perspective
por: Marjan Jahangiri, et al.
Publicado: (2020)

The ISCHEMIA Trial: And the Winner Is… the Patient
por: Pablo Avanzas, et al.
Publicado: (2021)

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

De-risking primary prevention: role of imaging
por: Ahmed M. Shafter, et al.
Publicado: (2021)

The ISCHEMIA Trial: What is the Message for the Interventionalist?
por: Emmanuel Ako, et al.
Publicado: (2021)

ISCHEMIA Trial: Key Questions and Answers
por: Jose Lopez-Sendon, et al.
Publicado: (2021)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Yong-zhe Guo, et al.
Publicado: (2021)

The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death
por: Leah A John, et al.
Publicado: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Efficacy of acetazolamide for the prophylaxis of acute mountain sickness: A systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials
por: Daiquan Gao, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Ahmadreza Karimianpour, et al.
Publicado: (2021)

Winter Peaks in Heart Failure: An Inevitable or Preventable Consequence of Seasonal Vulnerability?
por: Simon Stewart, et al.
Publicado: (2019)

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
por: Giuseppe Galati, et al.
Publicado: (2021)

Successful management of a foreseeable and preventable complication of transcatheter valve implantation
por: Ali Rıza Akyüz, et al.
Publicado: (2021)

Erratum to “Transseptal puncture via a superior access as an alternative to the conventional femoral route” [Int J Cardiol Congenit Heart Dis 4 (August 2021) 100187]
por: Silvia Guarguagli, et al.
Publicado: (2021)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)